| DOI | Resolve DOI: https://doi.org/10.1158/1538-7445.AM2017-4321 |
|---|
| Author | Search for: Aguadé-Gorgorio, Julia; Search for: McComb, Scott1; Search for: Eckert, Cornelia; Search for: Dobay, Maria Pamela; Search for: Cario, Gunnar; Search for: Mezzatesta, Caterina; Search for: Von Stackelberg, Arend; Search for: Stanulla, Martin; Search for: Martin, Schrappe; Search for: Bourquin, Jean-Pierre; Search for: Bornhauser, Beat C. |
|---|
| Affiliation | - National Research Council of Canada. Human Health Therapeutics
|
|---|
| Format | Text, Abstract |
|---|
| Conference | American Association for Cancer Research Annual Meeting 2017, April 1-5, 2017, Washington, DC, USA |
|---|
| Abstract | The identification of molecular determinants that regulate sensitivity to specific agents is essential for the development of new therapeutic approaches in cancer. We have earlier shown that a subset of refractory acute lymphoblastic leukaemia (ALL) samples respond to SMAC-mimetic (SM) induced IAP depletion by concurrently inducing RIP1-dependent apoptosis and necroptosis. Comparative gene expression profiling indicated a correlation of sensitivity to SM with the expression of TNF receptor 2 (TNFR2) in primary ALL. Using an independent cohort of primary chemotherapy-resistant ALL samples, we found that presence of high TNFR2 expression identified by qPCR predicted ex vivo-sensitivity to SM. High TNFR2 levels also correlated with higher expression of TNFR1. Deletion of either TNFR1 or TNFR2 using CRISPR/Cas9 in primary ALL conferred resistance to treatment with SM, indicating that TNFR1 and 2 are both functionally required for cell death. Concomitant with an important role for TNFR2 in the response to SM, the overexpression of TNFR2 leads to increased sensitivity to TNF through increased activation of the TNFR1/RIP1 death axis. On the mechanistic level, SM induced recruitment of RIP1 to TNFR1, which was abolished in cells deficient for TNFR2. Taken together, our data reveal a novel function of TNFR2 in cell death signalling, as TNFR2 predicts sensitivity to SMAC mimetics and plays a key role in modulating a switch from RIP1-controlled cell survival to cell death. |
|---|
| Publication date | 2017-07 |
|---|
| Publisher | American Association for Cancer Research |
|---|
| In | |
|---|
| Series | |
|---|
| Language | English |
|---|
| Peer reviewed | Yes |
|---|
| NPARC number | 23002150 |
|---|
| Export citation | Export as RIS |
|---|
| Report a correction | Report a correction (opens in a new tab) |
|---|
| Record identifier | b6b42a7f-48e0-4e99-b312-81e4a8c28802 |
|---|
| Record created | 2017-08-25 |
|---|
| Record modified | 2020-03-02 |
|---|
